Sun Pharma's Halol plant gets Form 483 with 10 observations from the USFDA

 The Sun Pharma's Halol facility was classified as 'Official Action Indicated (OAI)' in March 2020, and was awaiting re-inspection from the US regulator USFDA.

The USFDA has issued a Form 483 with 10 observations after inspection of Sun Pharma's Halol facility, the company said. Halol facility, however, at present has a very low contribution to the company’s turnover.

The Halol facility was classified as ‘Official Action Indicated (OAI)’ in March 2020, and was awaiting re-inspection from the US regulator. Due to the coronavirus (Covid-19) pandemic related travel restrictions, the re-inspection got delayed, and now the USFDA has issued Form 483 with observations, which is an improvement over the OAI status.

In a notification to the stock exchanges, Sun Pharma said that the US Food and Drugs Administration (USFDA) did a...read more

Comments

Post a Comment

Popular posts from this blog

Govt may not take up cryptocurrency Bill for now

Image
  The government had listed the Cryptocurrency and Regulation of Official Digital Currency Bill 2021 for tabling and passage in this session A Union Cabinet meeting on Wednesday did not discuss a Bill regulating cryptocurrencies, which means that Parliament’s Winter Session ending on December 23 is unlikely to take up the legislation. The government had listed the Cryptocurrency and Regulation of Official Digital Currency Bill 2021 for tabling and passage in this session. While the written listing had said that the Bill would prohibit all private cryptocurrencies in India, it was later clarified that the descriptor had been carried over from the listing of the Budget Session of Parliament. ger more updates on Economy & Policy here The Bill had not been introduced then and was not listed for the Monsoon Session either. Finance Secretary T V Somanathan and other officials have made two things clear: Cryptocurrencies will not be allowed as legal tender, and they may be ...
Read more

BharatPe to 'claw back' Ashneer's restricted shares, blocks vendors

Image
  BharatPe said it has initiated action against ex-founder Ashneer Grover to "claw back his restricted shares as per the shareholders' agreement" and will take steps to enforce its right under law. ading fintech platform BharatPe on Tuesday said it has initiated necessary action against the company's former founder Ashneer Grover to "claw back his restricted shares as per the shareholders' agreement" and will take all steps to enforce its right under the law. As part of its corporate governance review of the company after the financial irregularities were unearthed during Ashneer and his wife Madhuri Jain Grover's time, the company found many vendors were involved in malpractices, such as incorrect or inflated invoices, who have been blocked for further business with the company. "These vendors were also identified during the GST Enquiry. The company has already issued legal notices to... read more
Read more

Fortis case: Sebi slaps Rs 24 crore penalty on Singh brothers, 7 others

Image
The case pertains to misappropriation of funds by the erstwhile promoters and their related entities from Fortis Healthcare Market regulator the Securities and Exchange Board of India (Sebi) on Tuesday imposed a penalty of Rs 24 crore on nine entities including Malvinder Mohan Singh and Shivinder Mohan Singh for irregularities at Fortis Healthcare. The market regulator fined the Singh brothers Rs 5 crore each while their... read more
Read more